Search Results - "Stirnweiss, Anja"

Case Report: Long-Term Survival of a Pediatric Patient With an Intra-Abdominal Undifferentiated Carcinoma of Unknown Primary by Stirnweiss, Anja, Dholaria, Hetal, Oommen, Joyce, Hardy, Kathy, Jevon, Gareth, Beesley, Alex H., Kotecha, Rishi S.

“…An 8-year and 10-month-old boy presented following 2 weeks of abdominal pain, vomiting, constipation, and rectal pain. A diffuse lower-abdominal mass was felt…”
Get full text

Targeted SMN Exon Skipping: A Useful Control to Assess In Vitro and In Vivo Splice-Switching Studies by Flynn, Loren L, Mitrpant, Chalermchai, Adams, Abbie, Pitout, Ianthe L, Stirnweiss, Anja, Fletcher, Sue, Wilton, Steve D

“…The literature surrounding the use of antisense oligonucleotides continues to grow, with new disease and mechanistic applications constantly evolving…”
Get full text

Tumor suppression by IFN regulatory factor-1 is mediated by transcriptional down-regulation of cyclin D1 by KRÖGER, Andrea, STIRNWEISS, Anja, PULVERER, Julia Elisabeth, KLAGES, Katjana, GRASHOFF, Martina, REIMANN, Jörg, HAUSER, Hansjörg

“…IFNs have been ascribed to mediate antitumor effects. IFN regulatory factor-1 (IRF-1) is a major target gene of IFNs. It inhibits cell proliferation and…”
Get full text

IFN regulatory factor-1 bypasses IFN-mediated antiviral effects through viperin gene induction by Stirnweiss, Anja, Ksienzyk, Antje, Klages, Katjana, Rand, Ulfert, Grashoff, Martina, Hauser, Hansjörg, Kröger, Andrea

“…Viperin is an antiviral protein whose expression is highly upregulated during viral infections via IFN-dependent and/or IFN-independent pathways. We examined…”
Get full text

Molecular-genetic profiling and high-throughput in vitro drug screening in NUT midline carcinoma-an aggressive and fatal disease by Stirnweiss, Anja, Oommen, Joyce, Kotecha, Rishi S, Kees, Ursula R, Beesley, Alex H

“…NUT midline carcinoma (NMC) is a rare and aggressive cancer, with survival typically less than seven months, that can arise in people of any age. Genetically,…”
Get full text

Targeting Cross-Presentation as a Route to Improve the Efficiency of Peptide-Based Cancer Vaccines by Wylie, Ben, Ong, Ferrer, Belhoul-Fakir, Hanane, Priebatsch, Kristin, Bogdawa, Heique, Stirnweiss, Anja, Watt, Paul, Cunningham, Paula, Stone, Shane R, Waithman, Jason

“…Cross-presenting dendritic cells (DC) offer an attractive target for vaccination due to their unique ability to process exogenous antigens for presentation on…”
Get full text

T cell activation results in conformational changes in the Src family kinase Lck to induce its activation by Stirnweiss, Anja, Hartig, Roland, Gieseler, Steffi, Lindquist, Jonathan A, Reichardt, Peter, Philipsen, Lars, Simeoni, Luca, Poltorak, Mateusz, Merten, Camilla, Zuschratter, Werner, Prokazov, Yury, Paster, Wolfgang, Stockinger, Hannes, Harder, Thomas, Gunzer, Matthias, Schraven, Burkhart

“…The lymphocyte-specific Src family protein tyrosine kinase p56(Lck) (Lck) is essential for T cell development and activation and, hence, for adaptive immune…”
Get more information

PS1-109 IFN regulatory factor-1 bypasses IFN-mediated antiviral effects through viperin gene induction by Finsterbusch, Katja, Stirnweiss, Anja, Ksienzyk, Antje, Grashoff, Martina, Hauser, Hansjörg, Kröger, Andrea

Get full text

Case Report: Long-Term Survival of a Pediatric Patient With an Intra-Abdominal Undifferentiated Carcinoma of Unknown Primary by Stirnweiss, Anja, Dholaria, Hetal, Oommen, Joyce, Hardy, Kathy, Jevon, Gareth, Beesley, Alex H, Kotecha, Rishi S

Get full text